Primary outcome is the change in depressive symptoms measured by the PHQ-@ ; secondary outcomes include response , remission and relapse , functional quality of life ( SF-@ and EQ-@D-@ L ) , other clinical and psychosocial variables , direct and indirect costs , and the incremental cost-effectiveness ratio .